Dulce Garrido Bubacz

Title: Dulce Garrido Bubacz: Innovator in Therapeutic Agents

Introduction

Dulce Garrido Bubacz is a notable inventor based in Cary, NC (US). He has made significant contributions to the field of therapeutic agents, particularly in the treatment of non-insulin dependent diabetes mellitus. With a total of 8 patents, his work has had a considerable impact on medical research and treatment methodologies.

Latest Patents

Among his latest patents, one focuses on Kv2.1 antagonists. This invention relates to methods of treatment for non-insulin dependent diabetes mellitus, including the development of antagonists of the delayed rectifier potassium channel Kv2.1. The patent also covers methods for using and preparing these antagonists, as well as assays for identifying such antagonists. Another significant patent involves formamide compounds as therapeutic agents, which encompasses a family of compounds characterized by a specific structural formula.

Career Highlights

Dulce has worked with prominent companies in the pharmaceutical industry, including Delta Pharmaceuticals Ltd. and Glaxo Wellcome Inc. His experience in these organizations has allowed him to advance his research and contribute to innovative solutions in healthcare.

Collaborations

Throughout his career, Dulce has collaborated with esteemed colleagues, including Kwen-Jen Chang and Ann O. Davis. These partnerships have fostered a collaborative environment that enhances the development of new therapeutic approaches.

Conclusion

Dulce Garrido Bubacz's contributions to the field of therapeutic agents demonstrate his commitment to innovation and improving healthcare outcomes. His patents and collaborations reflect a dedication to advancing medical science and providing effective treatments for patients.